Saturday, 11 September 2021

PRO/AH/EDR> COVID-19 update (311): vaccines, nursing homes, long COVID, eating disorders

COVID-19 -- Worldwide/Unknown
Abstract
--------
"Conclusions: Many patients with a history of SARS-CoV-2 infection have antibodies specific for ACE2. Patients with ACE2 antibodies have lower activity of soluble ACE2 in plasma. Plasma from these patients also inhibits exogenous ACE2 activity. These findings are consistent with the hypothesis that ACE2 antibodies develop after SARS-CoV-2 infection and decrease ACE2 activity. This could lead to an increase in the abundance of Ang II, which causes a proinflammatory state

Read more about it at HealthMap Global Disease Alerts via http://healthmap.org/ln.php?8662043&promed&0

No comments:

Post a Comment